ArticleEULAR rheumatology open2025
The progression of initial symptoms and its relationship with the clinical course in adult-onset Still's disease: from the KEIO-AOSD cohort.
Article in EULAR rheumatology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Adult-onset Still's disease presents with nonspecific and heterogeneous features. This study aims to elucidate the development of initial symptoms and their relationship with the disease course in adult-onset Still's disease. Methods: We retrospectively reviewed consecutive patients with adult-onset Still's disease who had been enrolled in the KEIO-AOSD cohort from April 2012 to July 2024. Clinical information was collected from their medical records. Detailed initial symptoms and their relationship with disease courses were analyzed. Results: A total of 89 patients were included. The mean age at diagnosis was 46.3 ± 18.5 years, and 73.0% were females. The median time from the onset of initial symptoms to the first clinic visit, the first blood testing, satisfaction of Yamaguchi's criteria, and treatment initiation were 5.0, 10.0, 21.0, and 35.0 days, respectively. As initial symptoms, fever, was observed in 50.6%, rash and arthralgia in 37.1% each, and sore throat in 30.3%. Fever and sore throat rapidly increased within 2 weeks prior to Yamaguchi's criteria satisfaction. Patients with rash as an initial symptom tended to experience a delay in taking blood testing and satisfying Yamaguchi's criteria. Patients presenting with a sore throat as an initial symptom tended to show higher ferritin levels and experience macrophage activation syndrome. No significant differences were observed in long-term outcomes. Conclusions: Early clinical courses of adult-onset Still's disease varied depending on initial symptoms. Focusing on initial symptoms in clinical practice can contribute to earlier diagnosis and better management.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.